Revisiting the roles of cAMP signalling in the progression of prostate cancer (original) (raw)

Parsons, Emma C. ORCID: https://orcid.org/0000-0003-4693-2172, Baillie, George S. ORCID: https://orcid.org/0000-0003-2469-6316 and Hoffmann, Ralf(2023) Revisiting the roles of cAMP signalling in the progression of prostate cancer.Biochemical Journal, 480(20), pp. 1599-1614. (doi: 10.1042/BCJ20230297)

Abstract

Prostate cancer is one of the most common cancers in men and one of the top causes of death in men worldwide. Development and function of both normal prostate cells and early-stage prostate cancer cells are dependent on the cross-talk between androgen signalling systems and a variety of other transduction pathways which drive differentiation of these cells towards castration-resistance. One such signalling pathway is the ubiquitous cAMP signalling axis which functions to activate spatially restricted pools of cAMP effectors such as protein kinase A (PKA). The importance of both PKA and cAMP in the development of prostate cancer, and their interactions with the androgen receptor, were the focus of a review by Merkle and Hoffmann in 2010. In this updated review, we revisit this topic with analysis of current PKA-related prostate cancer literature and introduce novel information on the relevance of another cAMP effector, the exchange protein directly activated by cAMP (EPAC).

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details